Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors

Table 3 Population clinical characteristics and biochemical examinations of blood

	BeEOTs(n = 330, n^* = 347, n^※ = 305)	BEOTs(n = 49, n^* = 50, n^※ = 48)	MEOTs(n = 98, n^* = 116, n^※ = 109)	P value
Age	48.20 ± 13.04	47.61 ± 17.14	56.44 ± 7.79	0.001
Postmenopausal				0.002
No	148(44.85)	26(53.06)	25(25.51)
Yes	182(55.15)	23(46.94)	73(74.49)
CA-125	19.92 ± 29.00	89.82 ± 191.24	523.92 ± 835.60	<0.001
HE 4	51.92 ± 16.91	100.12 ± 124.28	260.23 ± 239.23	<0.001
Premenopausal ROMA index	9.23 ± 6.14	9.36 ± 5.77	47.81 ± 35.52	<0.001
Postmenopausal ROMA index	11.08 ± 3.68	20.06 ± 15.98	57.95 ± 30.22	0.001

The case number of BeEOTs(n) is 330 (unilateral 313, bilateral 17) with 347 tumors(n^*). The number of tumors with contrast enhanced MR imaging(n^※) is 305
The case number of BEOTs(n) is 49 (unilateral 48, bilateral 1) with 50 tumors(n^*). The number of tumors with contrast enhanced MR imaging (n^※) is 48
The case number of MEOTs(n) is 98 (unilateral 80, bilateral 18) with 116 tumors(n^*). The number of tumors with contrast enhanced MR imaging (n^※) is 109
The number in parenthesis is the percentage

ISSN: 1757-2215